Impact of the introduction of NORPLANT implants into the national family planning program of Thailand.
Leoprapai
B
B
D001208:Asia; D001210:Asia, Southeastern; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006285:Health Planning; D006297:Health Services Accessibility; D007267:Injections; D007434:Intrauterine Devices; D010342:Patient Acceptance of Health Care; D015995:Prevalence; D015397:Program Evaluation; D012106:Research; D012107:Research Design; D013223:Statistics as Topic; D013245:Sterilization, Reproductive; D013785:Thailand
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral
Acceptors, New; Acceptors--changes; Asia; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Availability; Contraceptive Implants; Contraceptive Methods; Contraceptive Methods Chosen--changes; Contraceptive Usage--changes; Cost Benefit Analysis; Developing Countries; Evaluation; Family Planning; Family Planning Program Evaluation; Family Planning Programs; Injectables; Iud; Measurement; Method Acceptability; Oral Contraceptives; Prevalence--changes; Quantitative Evaluation; Research Methodology; Research Report; Southeastern Asia; Statistical Studies; Sterilization, Sexual; Studies; Thailand